Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
Stopped early · Phase 2
Conditions studied: Cardiac Toxicity, Sarcoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. Giving chemotherapy after surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving chemotherapy before and after surgery works in treating patients with osteosarcoma.
Key facts
- Study ID
- NCT00019864
- Run by
- National Cancer Institute (NCI)
- People needed
- 100
- Starts
- 2000-03-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2015-06-08
Who can join
Age: any, up to 25. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States
- Oklahoma University Cancer Institute — Oklahoma City, Oklahoma, United States
- Cook Children's Medical Center - Fort Worth — Fort Worth, Texas, United States
- Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.